Last update:
Medications news
Medications
Combined oral contraceptive use among people with migraine with aura persists, despite cautions
Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological symptoms—due to a heightened ...
Dec 19, 2025
0
0
Medications
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?
Popular new anti-obesity medications can help people lose 10% to 20% of their body weight, yet a new study indicates that about 40% of those prescriptions go unfilled. Affordability, say researchers, is likely a factor.
Dec 18, 2025
0
0
Researchers seek better, safer alternatives to current opioid drugs
Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to provide pain relief, offering greater hope that new classes of these drugs may eventually be used to ...
Dec 18, 2025
0
0
High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. ...
Dec 17, 2025
0
0
Antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.
Dec 17, 2025
0
0
FDA approves Waskyra for Wiskott-Aldrich syndrome
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Dec 16, 2025
0
0
Little awareness of medical and psychological complexities of steroid cream withdrawal
There is little awareness, particularly among clinicians, of the medical and psychological complexities of "topical steroid withdrawal"—the body's adverse response to the prolonged use of these powerful creams to treat ...
Dec 16, 2025
0
1
FDA approves oral Nuzolvence and Blujepa for treating uncomplicated gonorrhea
The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection gonorrhea.
Dec 16, 2025
0
0
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.
Dec 16, 2025
0
0
Researchers develop programmable capsule to improve treatment for hormonal disorders
University of Mississippi researchers have designed a 3D-printed capsule that can release medication at exactly the moment a patient needs it, improving care for those who suffer from chronic illnesses.
Dec 16, 2025
0
0
Osteoporosis medicines might offer help for chronic pain after injury or surgery
A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer short-term pain relief for people with complex regional pain syndrome (CRPS), but the benefits ...
Dec 16, 2025
0
0
How statins cause muscle aches
Many people stop taking cholesterol-lowering statins because they experience muscle aches, weakness, and fatigue.
Dec 15, 2025
0
2
Cannabis derivatives could provide new ovarian cancer treatments
In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the effects of two chemical compounds sourced from cannabis on ovarian cancer cells have found that both show ...
Dec 15, 2025
0
0
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma
The U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatment or relapsed after two or more prior ...
Dec 15, 2025
0
0
FDA drug trials exclude a widening slice of Americans, research reveals
A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and Hispanic individuals.
Dec 13, 2025
0
63
Single-dose oral treatment for gonorrhea effectively combats drug-resistant infections, clinical trial finds
A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet.
Dec 11, 2025
0
23
Examining hidden risks of cannabis use among older adults
Cannabis use is rising among older adults, fueled by expanded legalization and people increasingly turning to cannabinoid-containing products to manage pain, sleep problems and other chronic issues.
Dec 11, 2025
0
0
ADHD prescriptions on the rise in Ontario, study finds
Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North York General, and The Hospital ...
Dec 11, 2025
0
0
EU to reward antibiotic innovation with new pharma rules
Drugmakers that develop new antibiotics are set to benefit from longer market protection in Europe after the EU agreed Thursday to a wide-ranging reform of pharmaceutical rules seeking to boost innovation and tackle antimicrobial ...
Dec 11, 2025
0
0
Plant used in folk medicine has anti-inflammatory anti-arthritic effects, study confirms
In Brazil, researchers from the Federal University of Grande Dourados (UFGD), the State University of Campinas (UNICAMP), and São Paulo State University (UNESP) have conducted a study that confirmed the safety and anti-inflammatory, ...
Dec 10, 2025
0
96
Slow tapering plus therapy most effective strategy for stopping antidepressants, research finds
For adults who have recovered from depression with the help of antidepressants, gradually reducing medication together with psychological support appears to be as effective as remaining on antidepressants for preventing relapse, ...
Dec 10, 2025
0
14
Sustained benefit seen for etranacogene dezaparvovec in hemophilia B
For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five years, according to a ...
Dec 10, 2025
0
0
Opioids: Clarifying the concept of safe supply to save lives
In Canada, thousands of people use contaminated street opioids. To reduce overdoses, the country has been experimenting for the past 10 years with the distribution of pharmaceutical opioids as an alternative to illicit drugs. ...
Dec 10, 2025
0
0
Stricter approval process reduces prescribing of anti-seizure drug that can cause birth defects
The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been effective at reducing the number of prescriptions issued for the drug, ...
Dec 10, 2025
0
0
GLP-1 medications show little effect on cancer, study shows
A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.
Dec 10, 2025
0
0
